NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Roche Holding AG (VX: ROG)

ROG Technical Analysis
As on 20th Jan 2022 ROG STOCK Price closed @ 365.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 320.82 & Strong Buy for SHORT-TERM with Stoploss of 307.56 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 365.80 Change Price %
High 366.20 1 Day -0.60 -0.16
Low 362.70 1 Week -10.45 -2.78
Close 365.10 1 Month -3.15 -0.86
Volume 950522 1 Year 47.20 14.85
52 Week High 383.60 | 52 Week Low 293.90
VX Switzerland Most Active Stocks
CSGN 9.13 0.77%
CSGN 9.13 0.77%
UBSG 17.68 0.11%
UBSG 17.68 0.11%
NOVN 81.39 -0.09%
NOVN 81.39 -0.09%
ABBN 34.39 1.15%
ABBN 34.39 1.15%
ARYN 1.11 -1.77%
ARYN 1.11 -1.77%
VX Switzerland Top Gainers Stocks
LOGN 74.68 2.50%
LOGN 74.68 2.50%
LOGN 74.68 2.50%
DUFN 49.60 2.42%
DUFN 49.60 2.42%
KNIN 270.00 2.27%
KNIN 270.00 2.27%
CLN 20.34 1.50%
CLN 20.34 1.50%
CLN 20.34 1.50%
VX Switzerland Top Losers Stocks
SGSN 2763.00 -2.61%
SGSN 2763.00 -2.61%
ADEN 49.45 -1.85%
ADEN 49.45 -1.85%
ARYN 1.11 -1.77%
ARYN 1.11 -1.77%
SLHN 587.40 -1.18%
SLHN 587.40 -1.18%
SREN 97.08 -0.41%
SREN 97.08 -0.41%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
ROG Important Levels Intraday
ROG Forecast September 2023
4th UP Forecast415.68
3rd UP Forecast399.46
2nd UP Forecast389.43
1st UP Forecast379.41
1st DOWN Forecast350.79
2nd DOWN Forecast340.77
3rd DOWN Forecast330.74
4th DOWN Forecast314.52
ROG Weekly Forecast
4th UP Forecast393.14
3rd UP Forecast384.15
2nd UP Forecast378.59
1st UP Forecast373.03
1st DOWN Forecast357.17
2nd DOWN Forecast351.61
3rd DOWN Forecast346.05
4th DOWN Forecast337.06
ROG Forecast2023
4th UP Forecast545.56
3rd UP Forecast487.69
2nd UP Forecast451.91
1st UP Forecast416.14
1st DOWN Forecast314.06
2nd DOWN Forecast278.29
3rd DOWN Forecast242.51
4th DOWN Forecast184.64
ROG Other Details
Segment EQ
Market Capital 0.00
Sector Other
Industry Other
Offical website >
ROG Address
ROG Latest News
Your Comments and Response on Roche Holding AG
ROG Business Profile
Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company provides diagnostic solutions, such as blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring; diabetes therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogeneous immuno assays; immunology; infectious diseases; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control service; real-time PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. Roche Holding AG has a strategic alliance with Wisconsin Diagnostic Laboratories; and a collaboration agreement with Five Prime Therapeutics, Inc. The company was founded in 1896 and is headquartered in Basel, Switzerland. Address:
© 2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service